Company

KYORIN Pharmaceutical

Japan

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold KYORIN Pharmaceutical?

Held by 33 covered funds. Sorted by KYORIN Pharmaceutical’s share of each fund. Holdings as of each fund’s latest SEC filing.

Fund	Category	Share of fund
KGGIXKopernik Global All-Cap Fund		0.5%
FDTSFirst Trust Developed Markets ex-US Small Cap AlphaDEX Fund		0.2%
DFJWisdomTree Japan SmallCap Dividend Fund	Japan	0.1%
ISVLiShares International Developed Small Cap Value Factor		0.0%
ISCFiShares International Small-Cap Equity Factor		0.0%
GWXSPDR(R) S&P(R) International Small Cap		0.0%
DISVDimensional International Small Cap Value		0.0%
SCJiShares MSCI Japan Small-Cap	Japan	0.0%
AVDSAvantis International Small Cap Equity		0.0%
SCHCSchwab International Small-Cap Equity		0.0%
VSSVanguard FTSE All-World Ex-US Small-Cap Index Fund		0.0%
DFISDimensional International Small Cap		0.0%
SCZiShares MSCI EAFE Small-Cap		0.0%
DXIVDimensional International Vector Equity		0.0%
DDLSWisdomTree Dynamic International SmallCap Equity Fund		0.0%
DLSWisdomTree International SmallCap Dividend Fund		0.0%
AVDNXAvantis International Equity Fund		0.0%
VPLVanguard Pacific Stock Index Fund	Asia-Pacific	0.0%
DDWMWisdomTree Dynamic International Equity Fund		0.0%
DFICDimensional International Core Equity 2		0.0%
IPACiShares Core MSCI Pacific	Asia-Pacific	0.0%
AVDEAvantis International Equity		0.0%
IEFAiShares Core MSCI EAFE		0.0%
DFSIDimensional International Sustainability Core 1	ESG & Sustainability	0.0%
DFAXDimensional World ex U.S. Core Equity 2		0.0%
IXUSiShares Core MSCI Total International Stock		0.0%
DFAIDimensional International Core Equity Market		0.0%
IDEViShares Core MSCI International Developed Markets		0.0%
VSGXVanguard ESG International Stock	ESG & Sustainability	0.0%
VEAVanguard Developed Markets Index Fund		0.0%
SSGVXState Street Global All Cap Equity ex-U.S. Index Portfolio		0.0%
VXUSVanguard Total International Stock Index Fund		0.0%
VTVanguard Total World Stock Index Fund		0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest KYORIN Pharmaceutical news

No recent stories about KYORIN Pharmaceutical.